(WH) Wyndham Hotels & Resorts - Overview
Stock: Franchise, Licensing, Loyalty, Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.98% |
| Yield on Cost 5y | 2.85% |
| Yield CAGR 5y | 16.84% |
| Payout Consistency | 94.0% |
| Payout Ratio | 44.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -42.07 |
| Character TTM | |
|---|---|
| Beta | 1.066 |
| Beta Downside | 1.102 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.17% |
| CAGR/Max DD | 0.06 |
Description: WH Wyndham Hotels & Resorts January 08, 2026
Wyndham Hotels & Resorts, Inc. (NYSE: WH) is a globally-focused hotel franchisor that licenses a broad portfolio of mid-scale and upscale brands-including Super 8, Days Inn, Ramada, and Wyndham Grand-to third-party owners, while also offering managed-service solutions and a guest loyalty program. Incorporated in 2017 and headquartered in Parsippany, New Jersey, the company generates the majority of its revenue from franchise fees, royalty payments, and marketing contributions rather than property ownership.
Key operating metrics show the franchise model’s resilience: FY 2023 reported a franchise-related revenue run-rate of roughly $1.2 billion, with an average daily rate (ADR) across its portfolio hovering near $115 and a revenue-per-available-room (RevPAR) growth of 4.5% year-over-year, driven by a rebound in domestic leisure travel and a modest increase in international demand. The company’s pipeline includes over 2,000 new openings slated through 2026, reflecting continued expansion in secondary markets where franchise fees are less sensitive to macro-economic cycles.
Sector-wide, hotel performance remains closely tied to discretionary spending trends, consumer confidence, and the trajectory of interest rates, which affect both corporate travel budgets and the cost of financing new hotel projects. A recent GDS (global distribution system) data release indicates that occupancy rates for mid-scale properties-Wyndham’s core segment-are trending 2-3 percentage points above the industry average, suggesting a competitive advantage in price-sensitive segments.
For a deeper quantitative view, you might explore ValueRay’s analyst dashboard to compare Wyndham’s franchise metrics against peers.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 338.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.84 > 1.0 |
| NWC/Revenue: 4.81% < 20% (prev -1.01%; Δ 5.82% < -1%) |
| CFO/TA 0.08 > 3% & CFO 349.0m > Net Income 338.0m |
| Net Debt (2.56b) to EBITDA (653.0m): 3.92 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.9m) vs 12m ago -2.90% < -2% |
| Gross Margin: 75.63% > 18% (prev 0.57%; Δ 7506 % > 0.5%) |
| Asset Turnover: 33.79% > 50% (prev 33.37%; Δ 0.42% > 0%) |
| Interest Coverage Ratio: 4.37 > 6 (EBITDA TTM 653.0m / Interest Expense TTM 135.0m) |
Altman Z'' 1.87
| A: 0.02 (Total Current Assets 508.0m - Total Current Liabilities 439.0m) / Total Assets 4.35b |
| B: 0.19 (Retained Earnings 811.0m / Total Assets 4.35b) |
| C: 0.14 (EBIT TTM 590.0m / Avg Total Assets 4.25b) |
| D: 0.22 (Book Value of Equity 813.0m / Total Liabilities 3.76b) |
| Altman-Z'' Score: 1.87 = BBB |
Beneish M -3.16
| DSRI: 1.10 (Receivables 326.0m/286.0m, Revenue 1.44b/1.39b) |
| GMI: 0.75 (GM 75.63% / 56.71%) |
| AQI: 0.98 (AQ_t 0.86 / AQ_t-1 0.87) |
| SGI: 1.04 (Revenue 1.44b / 1.39b) |
| TATA: -0.00 (NI 338.0m - CFO 349.0m) / TA 4.35b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of WH shares?
Over the past week, the price has changed by +6.18%, over one month by -3.27%, over three months by +7.82% and over the past year by -26.72%.
Is WH a buy, sell or hold?
- StrongBuy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 94.3 | 22% |
| Analysts Target Price | 94.3 | 22% |
| ValueRay Target Price | 76.8 | -0.6% |
WH Fundamental Data Overview February 03, 2026
P/E Forward = 14.556
P/S = 3.8705
P/B = 9.4356
P/EG = 0.9325
Revenue TTM = 1.44b USD
EBIT TTM = 590.0m USD
EBITDA TTM = 653.0m USD
Long Term Debt = 2.58b USD (from longTermDebt, last quarter)
Short Term Debt = 45.0m USD (from shortTermDebt, last quarter)
Debt = 2.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.56b USD (from netDebt column, last quarter)
Enterprise Value = 8.11b USD (5.56b + Debt 2.63b - CCE 70.0m)
Interest Coverage Ratio = 4.37 (Ebit TTM 590.0m / Interest Expense TTM 135.0m)
EV/FCF = 27.60x (Enterprise Value 8.11b / FCF TTM 294.0m)
FCF Yield = 3.62% (FCF TTM 294.0m / Enterprise Value 8.11b)
FCF Margin = 20.47% (FCF TTM 294.0m / Revenue TTM 1.44b)
Net Margin = 23.54% (Net Income TTM 338.0m / Revenue TTM 1.44b)
Gross Margin = 75.63% ((Revenue TTM 1.44b - Cost of Revenue TTM 350.0m) / Revenue TTM)
Gross Margin QoQ = 92.41% (prev 59.19%)
Tobins Q-Ratio = 1.87 (Enterprise Value 8.11b / Total Assets 4.35b)
Interest Expense / Debt = 1.37% (Interest Expense 36.0m / Debt 2.63b)
Taxrate = 26.06% (37.0m / 142.0m)
NOPAT = 436.3m (EBIT 590.0m * (1 - 26.06%))
Current Ratio = 1.16 (Total Current Assets 508.0m / Total Current Liabilities 439.0m)
Debt / Equity = 4.51 (Debt 2.63b / totalStockholderEquity, last quarter 583.0m)
Debt / EBITDA = 3.92 (Net Debt 2.56b / EBITDA 653.0m)
Debt / FCF = 8.70 (Net Debt 2.56b / FCF TTM 294.0m)
Total Stockholder Equity = 595.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.95% (Net Income 338.0m / Total Assets 4.35b)
RoE = 56.76% (Net Income TTM 338.0m / Total Stockholder Equity 595.5m)
RoCE = 18.57% (EBIT 590.0m / Capital Employed (Equity 595.5m + L.T.Debt 2.58b))
RoIC = 13.88% (NOPAT 436.3m / Invested Capital 3.14b)
WACC = 7.01% (E(5.56b)/V(8.18b) * Re(9.84%) + D(2.63b)/V(8.18b) * Rd(1.37%) * (1-Tc(0.26)))
Discount Rate = 9.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.51%
[DCF Debug] Terminal Value 80.42% ; FCFF base≈274.8m ; Y1≈246.9m ; Y5≈211.0m
Fair Price DCF = 28.16 (EV 4.68b - Net Debt 2.56b = Equity 2.13b / Shares 75.6m; r=7.01% [WACC]; 5y FCF grow -12.57% → 2.90% )
EPS Correlation: -14.11 | EPS CAGR: -46.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -8.01 | Revenue CAGR: -0.69% | SUE: -1.87 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.92 | Chg30d=-0.019 | Revisions Net=-2 | Analysts=11
EPS next Year (2026-12-31): EPS=5.02 | Chg30d=-0.042 | Revisions Net=-5 | Growth EPS=+10.5% | Growth Revenue=+5.7%